Literature DB >> 23642559

Magnetic resonance imaging of rectal cancer.

Luciana Costa-Silva1, Gina Brown.   

Abstract

Optimal treatment decisions for patients with rectal cancer are based on knowledge of tumor characteristics and prognostic features and any initial treatment must aim to reduce the risk of both local and distant recurrence. The radiologist has become an increasingly important part of multidisciplinary team managing rectal cancer. The primary goal of MRI staging of rectal tumors is to identify prognostic factors in order to offer patients a tailored treatment based on individual risks. Restaging of rectal tumors using MRI after chemoradiation therapy is becoming more relevant issue, since further tailoring of treatment is increasingly being considered after the treatment.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23642559     DOI: 10.1016/j.mric.2013.01.006

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  11 in total

Review 1.  MRI Local Staging and Restaging in Rectal Cancer.

Authors:  Gregory dePrisco
Journal:  Clin Colon Rectal Surg       Date:  2015-09

Review 2.  MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management.

Authors:  Natally Horvat; Camila Carlos Tavares Rocha; Brunna Clemente Oliveira; Iva Petkovska; Marc J Gollub
Journal:  Radiographics       Date:  2019-02-15       Impact factor: 5.333

Review 3.  Multiparametric MRI in rectal cancer.

Authors:  Bengi Gürses; Medine Böge; Emre Altınmakas; Emre Balık
Journal:  Diagn Interv Radiol       Date:  2019-05       Impact factor: 2.630

Review 4.  MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response.

Authors:  David D B Bates; Maria El Homsi; Kevin J Chang; Neeraj Lalwani; Natally Horvat; Shannon P Sheedy
Journal:  Clin Colorectal Cancer       Date:  2021-11-14       Impact factor: 4.481

Review 5.  Advances and challenges in treatment of locally advanced rectal cancer.

Authors:  J Joshua Smith; Julio Garcia-Aguilar
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

Review 6.  Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: a systematic review.

Authors:  Lorenzo Fornaro; Chiara Caparello; Caterina Vivaldi; Virginia Rotella; Gianna Musettini; Alfredo Falcone; Editta Baldini; Gianluca Masi
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 7.  Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences.

Authors:  Nieun Seo; Honsoul Kim; Min Soo Cho; Joon Seok Lim
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

8.  Accuracy of Magnetic Resonance Imaging in Staging Rectal Cancer with Multidisciplinary Team: A Single-Center Experience.

Authors:  Linzhen Yu; Liuhong Wang; Yinuo Tan; Hanguang Hu; Li Shen; Shu Zheng; Kefeng Ding; Suzhan Zhang; Ying Yuan
Journal:  J Cancer       Date:  2019-10-21       Impact factor: 4.207

9.  MRI cT1-2 rectal cancer staging accuracy: a population-based study.

Authors:  R Detering; S E van Oostendorp; V M Meyer; S van Dieren; A C R K Bos; J W T Dekker; O Reerink; J H T M van Waesberghe; C A M Marijnen; L M G Moons; R G H Beets-Tan; R Hompes; H L van Westreenen; P J Tanis; J B Tuynman
Journal:  Br J Surg       Date:  2020-04-16       Impact factor: 6.939

10.  T stage prediction of colorectal tumor based on multiparametric functional images.

Authors:  Yafang Dou; Xuefeng Tang; Yingying Liu; Zhigang Gong
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.